For research use only. Not for therapeutic Use.
Raltegravir potassium (Cat No.:I008974) is an antiretroviral medication used for the treatment of HIV-1 infection. It belongs to the class of integrase strand transfer inhibitors (INSTIs) and works by inhibiting the integrase enzyme, which is responsible for inserting the viral DNA into the host cell’s DNA. By blocking this process, raltegravir prevents the replication of the HIV virus and helps reduce viral load in the body. Raltegravir potassium has shown efficacy in both treatment-naive and treatment-experienced HIV patients and is often included as part of combination antiretroviral therapy regimens.
Catalog Number | I008974 |
CAS Number | 871038-72-1 |
Synonyms | MK0518; MK 0518; MK-0518; HSDB-8124; HSDB 8124; HSDB8124; Raltegravir; brand name: Isentress;potassium 4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-olate |
Molecular Formula | C20H20FKN6O5 |
Purity | ≥95% |
Target | Anti-infection |
Solubility | Soluble in DMSO. |
Storage | 0 - 4 °C for short term, or -20 °C for long term |
IUPAC Name | potassium;4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl]-6-oxopyrimidin-5-olate |
InChI | InChI=1S/C20H21FN6O5.K/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11;/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30);/q;+1/p-1 |
InChIKey | IFUKBHBISRAZTF-UHFFFAOYSA-M |
SMILES | CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)[O-])C(=O)NCC3=CC=C(C=C3)F.[K+] |
Reference | 1. Indian J Pharm Sci. 2014 Nov-Dec;76(6):557-9. <br><br> 2. Angew Chem Int Ed Engl. 2008;47(22):4134-6. doi: 10.1002/anie.200703681. |